NCT01050751View on ClinicalTrials.gov

Bioavailability Of Lersivirine Single 750 Mg Tablet Versus 3 X 250 Mg Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Healthy Volunteers

Interventions

DRUG

Lersivirine

Oral Lersivirine 750 mg (1 x 750 mg) single dose

DRUG

Lersivirine

Oral Lersivirine 750 mg (3 x 250 mg) single dose

Trial Locations (1)

1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY